Bar-Meir M, Elpeleg O N, Saada A
Metabolic Disease Unit, Shaare-Zedek Medical Center, Jerusalem, Israel.
J Pediatr. 2001 Dec;139(6):868-70. doi: 10.1067/mpd.2001.118885.
The effect of agents commonly used in the therapy of mitochondrial complex I deficiency was examined in fibroblasts from a patient. Marked improvement was observed with riboflavin, which nearly normalized the adenosine triphosphate production. The study of adenosine triphosphate production rate in fibroblasts may improve decision-making in treatment design of patients with respiratory chain defects.